Active ingredients: romiplostim
What it is used for
NPLATE is indicated for treatment of thrombocytopenia in patients aged 1 year and older with chronic immune (idiopathic) thrombocytopenic purpura (ITP): - who are non-splenectomised and have had an inadequate response, or are intolerant, to corticosteroids and immunoglobulins; - who are splenectomised and have had an inadequate response to splenectomy.
How to take it
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
White powder in 3 mL clear glass with chlorobutyl stopper, aluminium seal and propylene flip-off cap
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient romiplostim
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems